CytomX Therapeutics, Inc. (NASDAQ:CTMX) recently saw its volume around 3.35 million shares and on average it trades 0.26 million shares a day. The opening price of $24.34, led it to gain 21.53% to reach $23.09 upon the closing bell.

CytomX Therapeutics, Inc. (CTMX) Analyst Opinion

CytomX Therapeutics, Inc. has a consensus outperform rating from 6 Wall Street analysts, and the number of shares currently sold short amount to at least 3.58% of shares outstanding. The stock spiked 36.95% last month and is up 110.1 this year. Wall Street is only getting more bullish on the stock, with 5 of analysts who cover CTMX having a buy-equivalent rating. Analysts have placed a $28.25 price target on CytomX Therapeutics, Inc., suggesting a 22.35% gain from recent close. It’s currently trading about 15.33% above its 52-week high.

CytomX Therapeutics, Inc. Earnings Surprise

CytomX Therapeutics, Inc. (CTMX) revenue totaled $6.29 million down -46.01% from the previous quarter.

CytomX Therapeutics, Inc. (NASDAQ:CTMX) Intraday View

This stock (CTMX) is ahead of its 52-week low with 134.42%. Its last month’s stock price volatility remained 6.72% which for the week stands at 5.12%. The share price has moved forward from its 20 days moving average, trading at a distance of 31.68% and stays 45.92% away from its 50 days moving average. Over the last five days, shares have managed 28.85% gains and now is up 59.12% since hitting its 200-day moving average of $15.62. CytomX Therapeutics, Inc. (CTMX) has made its way to a 12-month gain of 49.06%.

Turning to Strongbridge Biopharma plc (NASDAQ:SBBP), its shares were trading at $6.1 a retreat of $-1.4, on the trading floor. The stock, after opening at $6.15, touched a high of $6.3 before paring much of its gains. So far, analysts are sticking with their bullish recommendations with the consensus call at 1.4. Strongbridge Biopharma plc has 3 buy ratings, 0 holds and 0 sells even after the stock tumbled -31.07% from its high of $8.85 to a $228.02 million market value through last close.

Strongbridge Biopharma plc (NASDAQ:SBBP) Intraday Trading

The counter witnessed a trading volume of 1.81 million shares versus an average volume of 0.07 million shares during last trading session. Its last month’s stock price volatility remained 7.19% which for the week approaches 6.91%. The lowest price the stock reached in the last trading day was $6 and compares with the $2 52-week low. The stock recovered 205% since its low point and has performed 154.17% year-to-date.